drugset / Trial / NCT00167856

Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury

NCT00167856 ↗

Completed 16 enrolled US Department of Veterans Affairs
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to evaluate the pain-relieving effects of venlafaxine hydrochloride (Effexor) in chronic neuropathic (burning, shock-like, electric) pain after spinal cord injury (SCI). Although a number of medications have been used to treat SCI pain, no drug has been consistently helpful, and, therefore, many people with SCI continue to have difficult chronic pain. Venlafaxine is a new anti-depressant drug that has not been tested for use in SCI neuropathic pain, but has been helpful for other types of neuropathic pain.

Timeline

Start
2005-06
Primary completion
2007-08
Completion
2008-08

Outcome

Missed primary endpoint

paper The average daily pain intensity as reported in the diary (primary outcome) was not significantly reduced by venlafaxine compared with placebo. PMID 11888224 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Venlafaxine Small molecule — —